gia, no controlled trials are available, although clinical reports are published.
Patients and methods
The authors have been utilising BTX type A and type B for headache since 1995. Patients were selected if they had headache resistant to conventional pharmacological medications.
Three injection techniques were used: 1. fixed points; 2. "follow the pain"; 3. combination of both.
The procedures were followed by a muscle stretching programme. Forty-one patients were submitted to repetition of procedure. Patients were checked 2 and 4 months after the procedure. Investigators, using a retrospective chart review, evaluated the number of headache attacks per month, headache intensity and drug consumption. Questions about quality of life were asked.
Results
To date 390 patients have been treated. They were 155 men and 235 women, with a mean age of 48 years (range 18-65 years). Patients suffered from: a. chronic tension-type headache (296 patients, 75.9%); b. chronic migraine (39 patients, 10%); c. daily headache with drug abuse (47 patients, 12%); d. other rare subtypes of headache (8 patients, 2%).
BTX type A was utilised in 374 patients (95.9%). The mean dosage of BTX type A was 80 IU (range 50-100 IU) for BOTOX or equivalent doses of other type of BTX.
Using a retrospective chart the number of headache attacks per months, headache intensity and drug consumption were recorded. Headache attacks per month were reduced in 82% of patients. Eighty-five percent of patients reported lower intensity of pain, 78% reduced drug intake. These data are comparable to data published by Blumenfeld [11] . No major side effects were reported. Only four patients displayed mild and transient ptosis. Ten patients complained of mild muscle weakness in the neck.
Discussion and conclusions
The inadequacy of current preventive treatment for disabling primary headache makes new treatments, such as [12] Migraine 29 III Wheeler, 1998 [13] Migraine plus tension-type headache 4 IV Klapper et al., 2000 [14] Migraine plus tension type headache 38 IB Ondo et al., 2004 [15] Chronic migraine, chronic tension-type headache 60 IB 
